Tudor Investment Corp
TERN

Tudor Investment Corp’s Terns Pharmaceuticals TERN Stock Holding History

Tudor Investment Corp’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.1M Buy
267,520
+194,274
+265% +$7.98M 0.03% 572
2025
Q4 		$2.96M Buy
+73,246
New +$1.69M 0.01% 1524
2024
Q4 		– Sell
-10,263
Closed -$85.6K – 3503
2024
Q3 		$85.6K Sell
10,263
-5,490
-35% -$45.2K ﹤0.01% 2601
2024
Q2 		$107K Buy
+15,753
New +$95.4K ﹤0.01% 2201

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Tudor Investment Corp's TERN Position: Q1 2026 in Review

Tudor Investment Corp increased its Terns Pharmaceuticals (TERN) stake by 265% in Q1 2026, buying an estimated $7.98M and bringing the position to 267,520 shares worth $14.1M. The position accounts for 0.03% of the portfolio, ranked #572.

Tudor Investment Corp first reported a position in TERN in Q2 2024 and has held it in 4 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Tudor Investment Corp held 267,520 shares of Terns Pharmaceuticals worth $14.1M as of Q1 2026.
  • Tudor Investment Corp bought 194,274 Terns Pharmaceuticals shares in Q1 2026, an estimated $7.98M.
  • Terns Pharmaceuticals made up 0.03% of Tudor Investment Corp's portfolio in Q1 2026, its #572 holding.
  • Tudor Investment Corp first reported a position in Terns Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.